This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Tübingen Hospital Experience With Intraoperative MRI Improves Patient Outcomes

VISIUS ® Surgical Theatre iMRI brings increased tumor resection and limits patient risks

MINNEAPOLIS, MN, June 12, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that University Hospital Tübingen neurosurgeons in Tübingen, Germany, are reporting success toward their objectives of limiting patient risk and improving surgical precision using intraoperative MRI for brain surgery procedures in the VISIUS ® Surgical Theatre since its June 2011 installation.

"Using intraoperative MRI in the VISIUS Surgical Theatre has enabled us to perform more resection and more complete tumor tissue removal without increasing the patient's risk of new neurological deficits," said Dr. Constantin Roder, a neurosurgeon at University Hospital Tübingen. "In some cases," he added, "we've been able to see and remove tumor-residuals that wouldn't have been possible without iMRI."

More than 150 procedures, primarily gliomas and pituitary tumors and other types of skull-based neurosurgeries, have been conducted in the Tübingen iMRI suite. After 100 cases, the hospital neurosurgical team states no adverse events or patient safety issues related to the iMRI have occurred, according to a review article in the Theatre and Surgery section of the current issue of Hospital Healthcare 2013. "Not moving the patient during surgery is an important part of minimizing patient risk," Roder said.

Retrospective analysis of patients after iMRI-guided resection of pituitary tumors (adenomas) shows that total resections improved in approximately 30 percent of the cases. 1,2 Roder states that the total resection experience of Tübingen neurosurgeons with 16 difficult pituitary adenomas was improved in up to 63 percent of the cases. In addition, iMRI use could be attributed, he said, to improved precision and preservation when tumors are located near sensitive areas or critical anatomical structures.

Roder also stated that the number of total resections of glioblastomas was improved significantly by iMRI-guided surgery compared with conventional surgery as was expected based on published evidence. A safe total resection of high-grade gliomas, he added, is known to be one of the most important prognostic factors to expand survival in these patients.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,678.23 -40.31 -0.23%
S&P 500 2,056.15 -4.90 -0.24%
NASDAQ 4,863.3620 -13.1570 -0.27%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs